Fred Hutchinson Cancer Research Center announced Thursday that Dr. Larry Corey will step down as President and Director.
Fred Hutch says Corey will focus on research to develop vaccines for HIV and herpes viruses. He will hold the title President and Director Emeritus and stay on as a member of the faculty.
"It is a privilege to have served as President and Director of The Hutch and I am proud that I have accomplished the strategic goals I set when I took the job," Corey said in a statement. "We have deepened our scientific leadership across all areas, improved our financial condition, commercialized important technology, and most importantly, have made significant scientific breakthroughs in the areas of immunotherapy and genomics."
Corey has served as President and Director since January 2011.
"The Hutch's loss of Larry as President and Director is a major gain for the field of HIV vaccine research. Dr. Corey is an extraordinary thought leader and practicing physician-scientist in this area and we welcome him back on a full-time basis to this critical area of biomedical research and global health, Dr. Anthony S. Fauci said in a statement. Dr. Fauci is the Director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
When Corey's resignation takes effect on June 30, Fred Hutch Deputy Director Dr. Mark Groudine will serve as Interim President and Director. The Board of Trustees has started a national search to replace Corey.